MA41930A1 - Composition for treatment of bayoud disease - Google Patents

Composition for treatment of bayoud disease

Info

Publication number
MA41930A1
MA41930A1 MA41930A MA41930A MA41930A1 MA 41930 A1 MA41930 A1 MA 41930A1 MA 41930 A MA41930 A MA 41930A MA 41930 A MA41930 A MA 41930A MA 41930 A1 MA41930 A1 MA 41930A1
Authority
MA
Morocco
Prior art keywords
bayoud
disease
treatment
composition
attacks
Prior art date
Application number
MA41930A
Other languages
French (fr)
Inventor
Omar Belmine
M'hamed Cherki
Damia Fares
Original Assignee
Omar Belmine
Cherki Mhamed
Damia Fares
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omar Belmine, Cherki Mhamed, Damia Fares filed Critical Omar Belmine
Priority to MA41930A priority Critical patent/MA41930A1/en
Publication of MA41930A1 publication Critical patent/MA41930A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L’invention concerne une composition pour traitement de la maladie du bayoud, qui attaque les palmiers dattiers.The invention relates to a composition for the treatment of bayoud disease, which attacks date palms.

MA41930A 2018-02-01 2018-02-01 Composition for treatment of bayoud disease MA41930A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA41930A MA41930A1 (en) 2018-02-01 2018-02-01 Composition for treatment of bayoud disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA41930A MA41930A1 (en) 2018-02-01 2018-02-01 Composition for treatment of bayoud disease

Publications (1)

Publication Number Publication Date
MA41930A1 true MA41930A1 (en) 2019-08-30

Family

ID=68425978

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41930A MA41930A1 (en) 2018-02-01 2018-02-01 Composition for treatment of bayoud disease

Country Status (1)

Country Link
MA (1) MA41930A1 (en)

Similar Documents

Publication Publication Date Title
EA202190983A1 (en) NEW ANTIBODY TO C-KIT
MA41013B1 (en) Compositions comprising bacterial strains
MA42560A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS OF BLAUTIA FOR THE TREATMENT OF VISCERAL HYPERSENSITIVITY
EA201890325A1 (en) PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR APPLICATION FOR THE TREATMENT OF INFLAMMATORY DISEASES
MA43335A (en) TRANSTHYRETINE (TTR) RNA COMPOSITIONS AND METHODS FOR USING THEM FOR THE TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH TTR
EA202092086A1 (en) ARGINASE INHIBITORS
MA39219B1 (en) New lrrk2 Kinase Inhibitor Compounds Used to Treat Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis
PH12018500578A1 (en) Methods of treating inflammatory diseases
MA52747A (en) TETRAHYDRO-1H-PYRAZINO [2,1-AJISOINDOLYLQUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
EA201892225A1 (en) ANTIBODIES TO THE COMPLEX Bb FACTOR AND THEIR APPLICATION
MA47395A (en) METHOD FOR THE TREATMENT OF NEUROLOGICAL DISEASE
EA202090401A1 (en) ANTI-TIM-3 ANTIBODIES AND THEIR APPLICATION
EA202090414A1 (en) COMPOUNDS AND THEIR APPLICATION
MA44864A (en) TRITHERAPY FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASE
EA202190807A1 (en) ANTIBODIES TO SYNUCLEINE
EA201990988A1 (en) ANTIBODIES AGAINST CHIKV AND WAYS OF THEIR APPLICATION
EA201890460A1 (en) COMPOSITIONS AND METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS
EA202192488A1 (en) ANTIBODIES AGAINST TSG-6 AND THEIR APPLICATIONS
MA41930A1 (en) Composition for treatment of bayoud disease
MA55218A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION
MA49607A1 (en) Monoclonal antibody for il-5ra
MA49375A (en) COMPOSITION FOR THE TREATMENT OF BLEPHARITIS
FR3057455B1 (en) EQUIPMENT FOR THE TREATMENT OF A FRACTURE BY HAUBANAGE, FOR EXAMPLE OF A FRACTURE OF THE OLECRANE OR THE BALL
MA40345B1 (en) New polymorphic form of n- [2- (6-fluoro-1h-indol-3-yl) ethyl] -3- (2,2,3,3-tetrafluoropropoxy) benzylamine hydrochloride for the treatment of disease. alzheimer
MA44836A (en) KIDNEY POLYCYSTIC SYNDROME TREATMENT METHODS